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The Kimmel Cancer Center and the Department of 
Health Policy Team with Aetna US Healthcare, Inc. 
and the National Cancer Institute to Define Standard 
of Care Treatment for Colorectal Cancer 
Colon cancer is a major cause of oncologic morbidity and mortality in the United 
States. Screening has been shown to detect early malignancy and decrease mortality 
and morbidity. As well, close follow up after resection of colorectal cancer, especially 
early stage cancers, has been shown to lead to earlier detection and management of 
recurrent disease. (1)  
 
In an attempt to identify strategies for limiting the devastating morbidity and 
mortality resulting from colorectal cancer, The Kimmel Cancer Center and Aetna US 
Healthcare (AUSHC), through a grant from the National Cancer Institute have 
established the Health Practices Research Program (HPR). HPR combines the clinical 
expertise available through Thomas Jefferson University and the Department of 
Health Policy with the large patient data sets created by AUSHC for the purpose of 
addressing the many questions concerning best treatment strategies for oncologic 
disease such as colorectal cancer.  
 
Numerous criteria, such as the MD Anderson Guidelines and the North Central 
Cancer Treatment Group recommendations, have been established to define 
treatment algorithms of highest quality for colorectal cancer. Unfortunately, there 
have been no large-scale randomized trials documenting the efficacy of standardized 
postoperative monitoring programs. (2) In an attempt to investigate the utility of 
standardized patterns of care, this important study describes "standard of care" 
(SOC) treatment for colorectal cancer and utilizes the SOC definition as an internal 
benchmark against which to compare the treatment received by USHC insured 
colorectal cancer patients.  
 
After a medical literature review of available guidelines, recommendations and 
consensus statements regarding the care of patients treated for colorectal cancer, 
interviews were conducted with TJUH medical, surgical and radiation oncologists. The 
medical literature and clinical consensus were then combined to develop a list of 
procedures and the timing of these procedures considered "SOC treatment" for 
colorectal cancer patients. SOC for the first year after treatment was defined as a 
history and physical every three months, CEA blood test every three months, liver 
function tests every three months, CT scans of the abdomen and pelvis every six 
months, chest x-ray annually, and colonoscopy annually.  
 
Patients were identified for the study from a listing of over 230,000 individuals 
eligible for fecal occult blood test screening. From this list, 268 individuals were 
identified with colorectal cancer related colectomy procedure codes from the AUSHC 
claims database. Of these individuals, 237 were confirmed by chart review to have a 
diagnosis of colorectal cancer between 1987 and 1990. A total of 222 individuals 
from this group with complete data was identified for the study. The utilization of 
procedures considered "SOC treatment" was assessed for these patients using the 
AUSHC claims and encounters data bases. Overall, the study population was found to 
be evenly distributed by age, gender and stage of disease.  
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Analysis of the data showed that during the first year after treatment, 81% of 
colorectal cancer patients received at least one documented physician encounter 
related to one or more SOC procedures. Overall, less than half of the study patients 
received CEA blood tests, liver function tests, chest x-rays, abdominal or pelvic CT 
scans, or colonoscopy during the study period. Additionally, patients with late stage 
disease received a statistically greater number of physician encounters and 
abdominal and pelvic CT scans than their early stage counterparts.  
 
Compared to the SOC, the actual reported receipt of procedures by colorectal cancer 
patients appears lower than one might expect. It should be recognized, however, 
that these results have been reached through comparison of the data to a SOC that 
may not be a completely accurate portrait of the clinical treatment universe. 
Although it may have limitations, the definition of SOC through the use of 
administrative data was necessary because, at present, there is no valid clinically 
derived database from which to create a benchmark for comparison to the study 
population.  
 
Ultimately, it is this author's belief that, as disease management programs have 
begun to show, some level of standardized care will likely improve both the process 
of care and the morbidity and mortality outcomes for patients with colorectal cancer. 
The question that now remains for TJUH, and healthcare in general, is what level of 
standardization of care is appropriate to achieve quality outcomes for its colorectal 
cancer patients? The results of this study underscore the imperative of finding an 
answer to this question. A critical step in this direction is the establishment of a 
national, controlled prospective study that explores the efficacy of standardized 
treatment algorithms for colorectal cancer through valid external benchmarks and 
standardized patterns of quality care.  
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